Ajanta Pharma has now brokered similar regional in-licensing deals for semaglutide, accelerating distribution across over 20 countries in the Middle East and Africa
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
For more fluid ideas, see our guide: The Ultimate Ozempic Hydration Guide: Water, Electrolytes & Tips
Despite being similar to natural GLP-1, liraglutide has a unique property - it is resistant to degradation by dipeptidyl peptidase 4 (DPP-4) and neutral endopeptidases (NEP)
Vibrant badgesFDA, GMP, Made in USAalongside bold banners like Up to 80% Off, See results in 7 days, and star ratingsgive off medical-grade credibility
